More to "The Point:" SHARx and Sophie Cunningham Turn a Viral Spotlight on Prescription Affordability
As the Missouri native's viral moment spreads far beyond basketball, SHARx says the bigger story is how trusted influenc …
JOTO PR Disruptors Names Norman Arjonilla COO to Scale Anti-PR Delivery and Performance
With more than two decades of experience building high-performance teams, quality-control systems, and measurable execut …
AI Agents Do Not Need Their Own Identity System. WinMagic Says One Architecture Can Cover All
With machine identities already outnumbering humans 82 to 1, WinMagic argues AI agents should be verified through a comm …
SHARx Says PBM Reform Should Be Measured by Results, Not Headlines
As states intensify oversight of PBMs, SHARx says the real measure of reform is whether it lowers costs, improves access …
Former Pfizer HQ Evacuation Puts Office Conversions Under Structural Scrutiny
With Los Angeles office vacancy at 25.6% and citywide adaptive reuse rules that could unlock more than 43,000 homes, Alp …
SHARx Says Pharmacy Benefits Have Become a Major Spend Category With No Clear Owner
SHARx says pharmacy benefits have become one of the employer's largest healthcare spend, yet responsibility remains frag …
From Wrong Answers to Wrong Actions: The New Risk of Agentic AI in Life Sciences
As AI agents move deeper into regulated scientific workflows, AINGENS argues that autonomy must be bound by evidence, tr …
When PR Is Working: The Business Outcomes Disruptive Companies Should Demand
Forget what you think PR success looks like. It’s not about the noise or the number of mentions. For disruptive companie …
Wisner Baum's Lawsuits Challenge FDA Oversight of Spinal Cord Implants
Wisner Baum has filed state and federal lawsuits alleging spinal cord stimulators marketed as safe and effective for chr …
